Upon receptor-regulated phosphorylation by TGF-β, pSMAD2/pSMAD3 forms a complex with SMAD4 and acts as a coactivator of numerous TGF-β target promoters in the nuclei that contributes to either tumorigenesis or tumor progression, depending on the context [21]. Here, SMAD4 is linked to neoplasm.